Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Inventory (2016 - 2025)

Historic Change in Inventory for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to -$57779.0.

  • China Pharma Holdings' Change in Inventory rose 8466.47% to -$57779.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$890206.0, marking a year-over-year increase of 3428.04%. This contributed to the annual value of -$1.6 million for FY2024, which is 952014.3% down from last year.
  • As of Q3 2025, China Pharma Holdings' Change in Inventory stood at -$57779.0, which was up 8466.47% from -$164804.0 recorded in Q2 2025.
  • China Pharma Holdings' 5-year Change in Inventory high stood at $552686.0 for Q1 2023, and its period low was -$679042.0 during Q2 2021.
  • In the last 5 years, China Pharma Holdings' Change in Inventory had a median value of -$211393.0 in 2021 and averaged -$193160.5.
  • As far as peak fluctuations go, China Pharma Holdings' Change in Inventory tumbled by 633519.71% in 2021, and later skyrocketed by 31180.69% in 2022.
  • Over the past 5 years, China Pharma Holdings' Change in Inventory (Quarter) stood at -$255815.0 in 2021, then increased by 24.59% to -$192902.0 in 2022, then tumbled by 34.09% to -$258659.0 in 2023, then tumbled by 97.56% to -$510996.0 in 2024, then skyrocketed by 88.69% to -$57779.0 in 2025.
  • Its last three reported values are -$57779.0 in Q3 2025, -$164804.0 for Q2 2025, and -$156627.0 during Q1 2025.